Abstract：Objective To explore the application effect of clinical pathway management under endoscopic treatment of colon polyps. Methods A total of 636 patients with colon polyps admitted to Jiangsu Shengze Hospital from July 2018 to April 2019 were selected as the research objects. All patients were treated under endoscopy, and were divided into clinical pathway group (334 cases) and non-clinical path waygroup (302 cases) according to different management methods. The hospitalization expenses, hospital stay time, postoperative gastrointestinal function recovery, satisfaction degree and incidence of complications were compared between the two groups. Results Compared with the non-clinical pathway group, the total hospitalization costs, surgical costs and drug costs of clinical pathway group were lower, and the differences were statistically significant (P ＜ 0.05). The clinical pathway group had shorter hospital stay time than that of the non-clinical pathway group, while the cost of hospitalization was lower than that of the non-clinical pathway group, and the differences were statistically significant (P ＜ 0.05). The first normal defecation time, the first liquid feeding time, and the general eating time of clinical pathway group were shorter than those of the non-clinical pathway group, and the differences were statistically significant (P ＜ 0.05). The comparison of patient satisfaction scores between the two groups showed that the patient satisfaction score of the clinical pathway group was higher than that of the non-clinical pathway group, and the differences were statistically significant (P ＜ 0.05). After management, the physiological function, social function, physical function and material life scores of the two groups were higher than before management, while the clinical pathway group were higher than those of the non-clinical pathway group, and the differences were statistically significant (P ＜ 0.05). Conclusion Patients are highly satisfied with the clinical pathway management of colon polyp endoscopic treatment. Treatment under the clinical pathway management is beneficial to reduce the total hospitalization cost of the patient, speed up the recovery time of the patient after surgery, shorten the hospital stay, and improve the living standard of the patient after treatment.
2021, Vol. 18 
京公网安备 11010502046598号